Intravenous Thrombolysis and Intra-Arterial Interventions in Acute Ischemic Stroke: Italian Stroke Organisation (ISO)-Spread Guidelines

1 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581–7.

2 Hacke W Kaste M Fieschi C . , for the ECASS-study group. Safety and efficacy of i.v. thrombolysis with a recombinant tissue plasminogen activator in the treatment of acute hemispheric stroke. JAMA 1995; 274:1017–25.

3 Hacke W Kaste M Fieschi C . Randomised double-blind placebo-controlled trial of thrombolytic therapy with i.v. alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet 1998; 352:1245–51.

4 Clark WM Wissman S Albers GW Jhamandas JH Madden KP Hamilton S . Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute non interventional therapy in ischemic stroke. JAMA 1999; 282:2019–26.

5 Hacke W Donnan G Fieschi C . , ATLANTIS Trials Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768–74.

6 Wahlgren N Ahmed N Dávalos A . SITS-MOST investigators Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275–82.

7 Hacke W Kaste M Bluhmki E . , for the European Cooperative Acute Stroke Study (ECASS) investigators. Alteplase compared with placebo within 3 to 4·5 hours for acute ischemic stroke. N Engl J Med 2008; 359:1317–29.

8 Wahlgren N Ahmed N Davalos A . , SITS investigators. Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372:1303–9.

9 The IST-3 collaborative group. The benefits and harms of i.v. thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379:2352–63.

10 Emberson J Lees KR Lyden P . , for the Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384:1929–35.

11 del Zoppo GJ Higashida RT Furlan AJ Pessin MS Rowley HA Gent M . PROACT: a phase II randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29:4–11.

12 Furlan A Higashida R Wechsler L . Intraarterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003–11.

13 Ogawa A Mori E Minematsu K . , for the MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle cerebral artery Embolism Local fibrinolytic intervention Trial (MELT) Japan. Stroke 2007; 38:2633–9.

14 Saver JL . Intra-Arterial fibrinolysis for acute ischemic stroke. The message of Melt. Stroke 2007; 38:2627–8.

15 Smith WS Sung G Starkman S . , MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36:1432–8.

16 Smith WS Sung G Saver J . , Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39:1205–12.

17 The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40:2761–8.

18 Saver JL Jahan R Levy EI . , SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380:1241–9.

19 Nogueira RG Lutsep HL Gupta R . , TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380:1231–40. [published correction appears in Lancet 2012;380:1230].

20 Ciccone A Valvassori L Nichelatti M . , for the SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. New Eng J Med 2013; 368:904–13.

21 Broderick JP Palesch YY Demchuk AM . , for the Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after I.v. t-PA versus t-PA alone for stroke. New Eng J Med 2013; 368:893–903.

22 Kidwell CS Jahan R Gornbein J . , for the MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368:914–23.

23 Molina CA . Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke 2010; 41:842–3.

Erratum in N Engl J Med 2015;372: 394.

25 Goyal M Demchuk AM Menon BK . , for the ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372:1019–30.

26 Campbell BCV Mitchell PJ Kleinig TJ . , for the EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372:1009–18.

27 Saver JL Goyal M Bonafe A . , for the SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372:2285–95.

28 Jovin TG Chamorro A Cobo E . , for the REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic strome. N Engl J Med 2015; 372:2296–306.

29 Mokin M Kass-Hout T Kass-Hout O . I.v. thrombolysis and endovascular therapy for acute Ischemic stroke with internal carotid artery occlusion: a systematic review of clinical outcomes. Stroke 2012; 43:2362–8.

30 Kappelhof M Marquering HA Berkhemer OA Majoie CBJ . Intraarterial treatment of patients with acute ischemic stroke and internal carotid artery occlusion: a literature review. J Neurointerv Surg 2015; 7:8–15.

31 Kumar G Shahripour RB Alexandrov AV . Recanalization of acute basilar artery occlusion improves outcomes: a meta-analysis. J Neurointerv Surg 2014. doi: 10.1136/neurintsurg-2014-011418; [Epub ahead of print].

32 Schonewille WJ Wijman CAC Michel P . , on behalf of the BASICS study group. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009; 8:724–30.

33 van der Hoeven EJ Schonewille WJ Vos JA . , for the BASICS Study Group. The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomized controlled trial. Trials 2013; 14:200.

34 Nedeltchev K Schwegler B Haefeli T . Outcome of stroke with mild or rapidly improving symptoms. Stroke 2007; 389:2531–5.

35 Steffenhagen N Hill MD Poppe AY Buchan AM Coutts SB . Should you thrombolyse all or any stroke patients with baseline National Institutes of Health Stroke Scale Scores ≤5? Cerebrovasc Dis 2009; 28:201–2.

36 Fink JN Kumar S Horkan C . The stroke patient who woke up. Clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002; 33:988–93.

37 Ebinger M Scheitz JF Kufner A Endres M Fiebach JB Nolte CH . MRI-based i.v. thrombolysis in stroke patients with unknown time of symptom onset. Eur J Neurol 2012; 19:348–50.

38 Petkova M Rodrigo S Lamy C . MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 2010; 257:782–92.

39 Manawadu D Bodla S Keep J Jarosz J Kalra L . An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke 2013; 44:427–31.

40 Selim M Kumar S Fink J Schlaung G Caplan LR Linfante I . Seizure at stroke onset: should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis 2002; 14:54–7.

41 Sylaja PN Dzialowski I Krol A Roy J Federico P Demchuk AM . Calgary Stroke Program. Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset. Stroke 2006; 37:915–7.

42 De Reuck J Vanhee F Van Maele G Claeys I . Magnetic resonance imaging after seizures in patients with an ischemic stroke. Cerebrovasc Dis 2007; 23:339–43.

43 Mishra NK Ahmed N Davalos A . , for the SITS and VISTA collaborators. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology 2011; 77:1866–72.

44 Karlinski M Kobayashi A Mikulik R . I.v. alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe. Int J Stroke 2012; 7:615–22.

45 Alhazzaa M Sharma M Blacquiere D Stotts G Hogan M Dowlatshahi D . Thrombolysis despite recent stroke: a case series. Stroke 2013; 44:1736–8.

46 Mazya MV Lees KR Markus R . , for the SITS investigators. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin. Ann Neurol 2013; 74:266–74.

47 Cappellari M Bovi P . I.v. thrombolysis for stroke in patients taking novel oral anticoagulants: a 2014 update. Thromb Haemost 2015; 114:440–4.

48 Steiner T Bohm M Dichgans M . Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol 2013; 102:399–412.

49 Hankey GJ Norrving B Hacke W Steiner T . Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke 2014; 9:627–32.

50 Matute MC Masjuan J Egido JA . Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with Anticoagulants. Cerebrovasc Dis 2012; 33:231–9.

51 Inzitari D Arba F Piccardi B Poggesi A . Predictors of hemorrhagic transformation of ischemic stroke after thrombolysis; in Micieli G Amantea D (eds): Rational Basis for Clinical Translation in Stroke Therapy. Clinical Needs: Diagnosis and Brain Imaging Techniques, Frontiers in Neurotherapeutics Series. Boca Raton, FL, CRC Press, 2015:165–88.

52 Meretoja A Putaala J Tatlisumak T . Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010; 41:1450–8.

53 Guillan M Alonso-Canovas A Garcia-Caldentey J . Off-label i.v. thrombolysis in acute stroke. Eur J Neurol 2012; 19:390–4.

54 Neil W Ovbiagele B . Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Rep Med 2011; 2011:503758. Article ID 503758, 3 pages.

55 Edwards NJ Hooman K Josephson SA . The safety of i.v. thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms. A case series and review of the literature. Stroke 2012; 43:412–6.

56 Katz BS Flemming KD . Successful IV thrombolysis followed by mechanical thrombectomy in a patient with cerebral ischemia and a dural AV fistula. Am J Emerg Med 2013; 31:637.

57 Sumner CJ Golden JA Hemphill JC 3rd . Should thrombolysis be contraindicated in patients with cerebral arteriovenous malformations? Crit Care Med 2002; 30:2359–62.

58 Cronin CA Weisman CJ Llinas RH . Stroke treatment. Beyond the three hour window and in the pregnant patient. Ann N Y Acad Sci 2008; 1142:159–78.

59 Mantoan Ritter L Schüler A Gangopadhyay R . Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol 2014; 261:632–4.

60 Demchuk AM . Yes I.v. thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable. Stroke 2013; 44:864–5.

61 Tassi R Acampa M Marotta G . Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med 2013; 31:448.e1–3.

62 Wein TH Hickenbottom SL Morgenstern LB Demchuk AM Grotta JC . Safety of tissue plasminogen activator for acute stroke in menstruating women. Stroke 2002; 33:2506–8.

63 Breuer L Blinzler C Huttner HB Kiphuth IC Schwab S Köhrmann M . Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of ‘minor stroke’. Cerebrovasc Dis 2011; 32:177–85.

64 Zinkstok SM Vergouwen MD I Engelter ST . Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke. A Meta-Analysis of Individual Patient Data. Stroke 2011; 42:2515–20.

65 Heldner MR Zubler C Mattle HP . National Institutes of Health Stroke Scale Score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke 2013; 44:1153–7.

66 Cooray C Fekete K Mikulik R Lees KR Wahlgren N Ahmed N . Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis. Int J Stroke 2015; 10:822–9.

67 Meyers P Schumacher HC Higashida RT . Indications for the performance of intracranial endovascular neurointerventional procedures. A scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. J Neurointervent Surg 2010; 2:177–88.

68 Moey AW Koblar SA Chryssidis S Robinson M Jannes J . Endovascular therapy after stroke in a patient treated with dabigatran. Med J Aust 2012; 196:469–71.

69 Müller P Topakian R Sonnbergerb M . Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran. Clin Neurol Neurosurg 2013; 115:2257–9.

70 Mehta S Dababneh H Hussain M Moussavi M Kirmani JF . Endovascular treatment in acute ischemic stroke patient on factor Xa inhibitor. J Vasc Interv Neurol 2014; 14:5–7.

71 Kimura S Ogata T Fukae J . Revascularization for acute ischemic stroke is safe for rivaroxaban users. J Stroke Cerebrovasc Dis 2014; 23:e427–31.